Maryland2026Active
HB0027
Maryland Long COVID Innovation Grant and Loan Program
Last scannedAug 22, 2026, 4:24 AM
In one sentence
This law requires the Maryland Technology Development Corporation to create a program that gives grants and loans for research, product development, and manufacturing related to treating Long COVID.
What it does
- Creates a new grant and loan program managed by the Maryland Technology Development Corporation.
- Establishes the Maryland Long COVID Research Fund as a special account where money does not expire at the end of the year.
- Requires the Corporation to contract with an independent committee of scientific experts to review research proposals.
- Sets rules for how grants and loans are awarded, monitored, and returned if goals are not met.
- Mandates that any interest earned on the fund's money must be added back into the fund.
Who it affects
- The Maryland Technology Development Corporation
- Public and private entities in Maryland applying for research funding
- Scientific experts serving on the independent review committee
Limits and unknowns
- The law does not specify how much total money will be put into the fund, only that it comes from state budgets or other accepted sources.
- Specific details on application deadlines and exact grant amounts are left for future regulations to decide.
Plain language
Terms to know
- Long COVID Innovation
- Research, product development, and manufacturing in Maryland related to treating Long COVID using money from this fund.
- Nonlapsing Fund
- A special account where unused money stays available for future use instead of being returned at the end of a budget year.
Official record
Sources
Official summary
Requiring the Maryland Technology Development Corporation to establish a grant and loan program to provide grants and loans for Long COVID innovation; requiring the Corporation to contract with an independent review committee composed of scientific experts in the field of Long COVID; establishing the Maryland Long COVID Research Fund under the administration of the Corporation as a special, nonlapsing fund; and requiring that the interest earnings of the Fund be credited to the Fund.
Official activity
Bill history
- In the House - Hearing 2/10 at 2:30 p.m.